Development and validation of a novel endoplasmic reticulum stress-related lncrna prognostic signature and candidate drugs in breast cancer

HIGHLIGHTS

• who: August and collaborators from the Yancheng Teachers University, China have published the article: Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancer, in the Journal: (JOURNAL)
• what: The study showed that the mutation rate of gene TP53 was highest in high-risk patients, while the mutation rate of gene PIK3CA was highest in low-risk patients. Taken together, the model the authors constructed can be considered as a good prognostic signature whose mechanism of action in BC deserves further exploration and validation. For those . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.